Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

MRK 3Q18 items…

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 721
Posts 108,625
Boards Moderated 21
Alias Born 09/05/02
160x600 placeholder
Merck's Bacterial-Infection Drug Recarbrio Approved by FDA Dow Jones News - 7/17/2019 7:45:00 AM
FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, & relebactam) For the Treatment of Adults with Complicated Urinary... Business Wire - 7/17/2019 6:45:00 AM
Merck on Pace for Largest Percent Decrease Since October 2017 -- Data Talk Dow Jones News - 7/11/2019 2:43:00 PM
Merck Highlights Commitment to HIV Research with Presentations for Investigational Anti-HIV Agent MK-8591 at IAS 2019 Business Wire - 7/10/2019 6:45:00 AM
Drugmakers Rise After Trump Pricing Rule Is Blocked Dow Jones News - 7/9/2019 1:58:00 PM
Merck Sees FDA OK for Six-Week Keytruda Dosing in Six Indications Dow Jones News - 7/9/2019 7:27:00 AM
FDA Accepts Merck’s Supplemental Biologics License Applications for KEYTRUDA® (pembrolizumab) Six-Week Dosing Schedule for... Business Wire - 7/9/2019 6:45:00 AM
Trump Rule Requiring Drug Prices in TV Ads Blocked -- Update Dow Jones News - 7/8/2019 10:25:00 PM
Trump Rule Requiring Drug Prices in TV Ads Blocked Dow Jones News - 7/8/2019 9:34:00 PM
Skyhawk Therapeutics Says to Work With Merck to Develop Drug Candidates Dow Jones News - 7/8/2019 8:29:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:25:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:23:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:20:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:17:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 5:08:56 PM
Merck to Hold Second-Quarter 2019 Sales and Earnings Conference Call on July 30 Business Wire - 7/1/2019 6:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/27/2019 5:06:23 PM
Merck Says CDC Committee Recommends HPV Vaccine for Men and Women Through 26 Dow Jones News - 6/26/2019 6:40:00 PM
CDC Advisory Committee on Immunization Practices (ACIP) Votes to Provisionally Recommend Shared Clinical Decision-Making for ... Business Wire - 6/26/2019 4:45:00 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/20/2019 3:25:26 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/20/2019 3:23:46 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/20/2019 3:22:15 PM
Merck Hosts 2019 Investor Day Outlining Bus. Momentum, Strong Expected Growth & Focus on Innovative Research & Development Business Wire - 6/20/2019 6:45:00 AM
Merck Seeks Deals As It Expands Its Cancer Treatments -- WSJ Dow Jones News - 6/20/2019 3:02:00 AM
AstraZeneca & Merck’s LYNPARZA® (olaparib) Approved in Japan as First-Line Maintenance Therapy in Patients with BRCA-Mutat... Business Wire - 6/19/2019 6:45:00 AM
DewDiligence Member Level  Thursday, 10/25/18 09:18:16 AM
Re: DewDiligence post# 376
Post # of 469 
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist